Mesenteric adenopathy in patients with prostate cancer: frequency and etiology.
OBJECTIVE
This study was undertaken to determine the frequency and etiology of mesenteric adenopathy revealed at initial-staging CT in patients with prostate cancer.


CONCLUSIONS
Mesenteric adenopathy is a rare finding at initial-staging CT in patients with prostate cancer and is more often due to coexistent lymphoma than to metastatic disease, particularly in the absence of associated pelvic adenopathy and a markedly elevated serum prostate-specific antigen level. Appropriate radiologic interpretation of the finding prevents overstaging of prostate cancer.
Coakley
Fergus V
FV
Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021, USA.
Lin
Rudolph Y
RY
Schwartz
Lawrence H
LH
Panicek
David M
DM
D000368:Aged; D001706:Biopsy; D003937:Diagnosis, Differential; D006801:Humans; D008198:Lymph Nodes / Q000000981:diagnostic imaging* / Q000473:pathology; D008207:Lymphatic Metastasis; D008228:Lymphoma, Non-Hodgkin / Q000000981:diagnostic imaging / Q000473:pathology; D008297:Male; D008643:Mesentery / Q000000981:diagnostic imaging / Q000473:pathology; D008875:Middle Aged; D009367:Neoplasm Staging; D009378:Neoplasms, Multiple Primary / Q000000981:diagnostic imaging / Q000473:pathology; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D012189:Retrospective Studies; D014057:Tomography, X-Ray Computed